<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - BRL</title>
<description>International Business News - BRL</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Sector Snap: Wachovia cuts generic drugmakers</title>
  <description>Investment bank Wachovia downgraded four of the largest generic drug companies Monday, indicating it expects them to perform about as well as the overall market.</description>
    <link>http://www.ibtimes.com/articles/20080721/sector-snap-wachovia-cuts-generic-drugmakers.htm</link> 
  <pubDate>Mon, 21 Jul 2008 15:16:51 EDT</pubDate>
  </item>


  <item>
  <title>Business Highlights</title>
  <description>Oil prices tumble in biggest weekly drop ever NEW YORK (AP)--The price of oil recorded its biggest weekly drop ever, and a gallon of gas finally pulled back from its record high. So is it time to declare the energy bubble popped? Experts won't go that far just yet.</description>
    <link>http://www.ibtimes.com/articles/20080718/business-highlights.htm</link> 
  <pubDate>Fri, 18 Jul 2008 18:34:42 EDT</pubDate>
  </item>


  <item>
  <title>S&amp;P maintains negative credit outlook for Barr</title>
  <description>Standard &amp; Poor's Ratings Services reaffirmed its negative outlook for Barr Pharmaceuticals Inc.'s corporate credit rating, citing the proposed sale of the drug developer to rival Teva Pharmaceutical Industries Ltd.</description>
    <link>http://www.ibtimes.com/articles/20080718/s-p-maintains-negative-credit-outlook-for-barr.htm</link> 
  <pubDate>Fri, 18 Jul 2008 15:10:56 EDT</pubDate>
  </item>


  <item>
  <title>Citi, Schlumberger, Google, Mattel are big movers</title>
  <description>Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSE</description>
    <link>http://www.ibtimes.com/articles/20080718/citi-schlumberger-google-mattel-are-big-movers.htm</link> 
  <pubDate>Fri, 18 Jul 2008 16:40:35 EDT</pubDate>
  </item>


  <item>
  <title>Teva to buy Barr Pharma for more than $7 billion</title>
  <description>Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.</description>
    <link>http://www.ibtimes.com/articles/20080718/teva-to-buy-barr-pharma-for-more-than-7-billion.htm</link> 
  <pubDate>Fri, 18 Jul 2008 16:06:13 EDT</pubDate>
  </item>


  <item>
  <title>Wall Street mixed after earnings reports</title>
  <description>Wall Street closed out an impressive week with a mixed performance Friday after disappointing high-tech earnings punctured some of investors' enthusiasm over better-than-expected bank earnings reports. But the major indexes still ended the week with big gains, the result of rising optimism about the troubled financial sector.</description>
    <image>
  <url>http://www.ibtimes.com/data/articleimgs/93527-wall-street.jpg</url>
  <link>http://www.ibtimes.com/articles/20080718/wall-street-heads-to-higher-open-on-mixed-earnings.htm</link>
  </image>
    <link>http://www.ibtimes.com/articles/20080718/wall-street-heads-to-higher-open-on-mixed-earnings.htm</link> 
  <pubDate>Fri, 18 Jul 2008 17:34:45 EDT</pubDate>
  </item>


  <item>
  <title>Sector roundup: Generic drug makers, chips</title>
  <description>Among the sector activity stories for Thursday, July 17, from AP Financial News: NEW YORK (AP)--Shares of Barr Pharmaceuticals Inc. soared Thursday on reports of buyout talks between Barr and industry leader Teva Pharmaceutical Industries Ltd. The speculation also lifted shares of other generic drug makers.</description>
    <link>http://www.ibtimes.com/articles/20080717/sector-roundup-generic-drug-makers-chips.htm</link> 
  <pubDate>Thu, 17 Jul 2008 18:02:35 EDT</pubDate>
  </item>


  <item>
  <title>Sector roundup: Generic drugs, investment banks</title>
  <description>Among the sector activity stories for Thursday, July 17, from AP Financial News: NEW YORK (AP)--Shares of Barr Pharmaceuticals Inc. soared Thursday on reports of buyout talks between Barr and industry leader Teva Pharmaceutical Industries Ltd., lifting shares of other generic drug makers.</description>
    <link>http://www.ibtimes.com/articles/20080717/sector-roundup-generic-drugs-investment-banks.htm</link> 
  <pubDate>Thu, 17 Jul 2008 14:28:08 EDT</pubDate>
  </item>


  <item>
  <title>JPMorgan, Harley, eBay, Starbucks among big movers</title>
  <description>Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSE</description>
    <link>http://www.ibtimes.com/articles/20080717/jpmorgan-harley-ebay-starbucks-among-big-movers.htm</link> 
  <pubDate>Thu, 17 Jul 2008 16:55:16 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Teva-Barr talk lifts generics makers</title>
  <description>Shares of Barr Pharmaceuticals Inc. soared Thursday on reports of buyout talks between Barr and industry leader Teva Pharmaceutical Industries Ltd. The speculation also lifted shares of other generic drug makers.</description>
    <link>http://www.ibtimes.com/articles/20080717/sector-snap-teva-barr-talk-lifts-generics-makers.htm</link> 
  <pubDate>Thu, 17 Jul 2008 15:17:07 EDT</pubDate>
  </item>


  <item>
  <title>Premarket roundup: Starbucks, Barr Pharma, Teva</title>
  <description>Among the premarket stories for Thursday, July 17, from AP Financial News: NEW YORK (AP)--An analyst downgraded Starbucks Corp. on Thursday, saying the coffee retailer's turnaround will likely take longer than previously expected.</description>
    <link>http://www.ibtimes.com/articles/20080717/premarket-roundup-starbucks-barr-pharma-teva.htm</link> 
  <pubDate>Thu, 17 Jul 2008 10:02:45 EDT</pubDate>
  </item>


  <item>
  <title>Barr climbs to 2-year high on Teva buyout reports</title>
  <description>Shares of generic drug maker Barr Pharmaceuticals Inc. surged to a nearly two-year high on Thursday as media reports indicated the company is in talks to be bought out by Israeli rival Teva Pharmaceutical Industries Ltd.</description>
    <link>http://www.ibtimes.com/articles/20080717/ahead-of-the-bell-barr-climbs-on-buyout-reports.htm</link> 
  <pubDate>Thu, 17 Jul 2008 15:06:27 EDT</pubDate>
  </item>


  <item>
  <title>Generic drug group spent $434,495 lobbying in 1Q</title>
  <description>The Generic Pharmaceutical Association spent $434,495 lobbying in the first quarter on issues affecting the drug industry, according to a recent disclosure report.</description>
    <link>http://www.ibtimes.com/articles/20080630/generic-drug-group-spent-434-495-lobbying-in-1q.htm</link> 
  <pubDate>Mon, 30 Jun 2008 08:38:02 EDT</pubDate>
  </item>


  <item>
  <title>Barr Pharmaceuticals spent $1.7M lobbying in 1Q</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. spent nearly $1.7 million in the first quarter lobbying on legislation affecting the drug industry, according to a recent disclosure form.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-pharmaceuticals-spent-1-7m-lobbying-in-1q.htm</link> 
  <pubDate>Fri, 27 Jun 2008 16:05:51 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Barr Pharmaceuticals, Palm</title>
  <description>Among the stock activity stories for Friday, June 27, from AP Financial News: NEW YORK (AP)--Shares of Barr Pharmaceuticals Inc. rose Friday as a Delaware federal court invalidated several patents covering Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s Mirapex, opening the door for a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/movers-roundup-barr-pharmaceuticals-palm.htm</link> 
  <pubDate>Fri, 27 Jun 2008 14:40:19 EDT</pubDate>
  </item>


  <item>
  <title>Barr shares rise on Mirapex patent case victory</title>
  <description>Shares of Barr Pharmaceuticals Inc. rose Friday as a Delaware federal court invalidated several patents covering Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s Mirapex, opening the door for a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-shares-rise-on-mirapex-patent-case-victory.htm</link> 
  <pubDate>Fri, 27 Jun 2008 12:38:40 EDT</pubDate>
  </item>


  <item>
  <title>Barr scores victory in patent challenge on Mirapex</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. said late Thursday it won a patent challenge regarding Boehringer Ingelheim Pharmaceuticals Inc.&amp;#39;s drug Mirapex, increasing the possibility of a generic launch.</description>
    <link>http://www.ibtimes.com/articles/20080627/barr-scores-victory-in-patent-challenge-on-mirapex.htm</link> 
  <pubDate>Fri, 27 Jun 2008 10:54:45 EDT</pubDate>
  </item>


  <item>
  <title>Barr shares rise on Bayer birth control pills deal</title>
  <description>Shares of Barr Pharmaceuticals Inc. rose Tuesday after the generic drug company announced an agreement to sell two Bayer birth control pills years before the last patents expire on the products.</description>
    <link>http://www.ibtimes.com/articles/20080624/barr-shares-rise-on-bayer-birth-control-pills-deal.htm</link> 
  <pubDate>Tue, 24 Jun 2008 12:24:56 EDT</pubDate>
  </item>


  <item>
  <title>Barr to sell generic Bayer birth control pills</title>
  <description>Generic drug maker Barr Pharmaceuticals Inc. said Tuesday it signed an agreement with German pharmaceutical company Bayer AG to sell a generic version of the birth control pill Yasmin on or before July 1, several years before the last patent on the product expires.</description>
    <link>http://www.ibtimes.com/articles/20080624/barr-to-sell-generic-bayer-birth-control-pills.htm</link> 
  <pubDate>Tue, 24 Jun 2008 08:00:11 EDT</pubDate>
  </item>


  <item>
  <title>Doctors may soon prescribe addictive drugs online</title>
  <description>Government regulators said Thursday they are preparing to allow highly addictive medications, including powerful painkillers, to be prescribed online, a goal long-sought by health insurers and large employers.</description>
    <link>http://www.ibtimes.com/articles/20080619/doctors-may-soon-prescribe-addictive-drugs-online.htm</link> 
  <pubDate>Thu, 19 Jun 2008 18:14:43 EDT</pubDate>
  </item>


</channel>
</rss>